| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
|
Lancet
|
2007
|
2.48
|
|
2
|
Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.
|
Proc Natl Acad Sci U S A
|
2003
|
2.45
|
|
3
|
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
|
J Am Coll Cardiol
|
2006
|
2.44
|
|
4
|
Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.
|
Proc Natl Acad Sci U S A
|
2002
|
2.27
|
|
5
|
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
|
Circulation
|
2009
|
1.95
|
|
6
|
Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
|
Circ Res
|
2003
|
1.82
|
|
7
|
Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells.
|
Proc Natl Acad Sci U S A
|
2007
|
1.75
|
|
8
|
AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation.
|
Nat Cell Biol
|
2010
|
1.72
|
|
9
|
Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.
|
J Am Coll Cardiol
|
2009
|
1.71
|
|
10
|
Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2009
|
1.63
|
|
11
|
Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload.
|
Circulation
|
2010
|
1.63
|
|
12
|
A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart.
|
J Clin Invest
|
2007
|
1.61
|
|
13
|
Prevalence and clinical implication of metabolic syndrome in chronic heart failure.
|
Circ J
|
2010
|
1.51
|
|
14
|
Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy.
|
Hypertens Res
|
2006
|
1.42
|
|
15
|
Serum blood urea nitrogen and plasma brain natriuretic Peptide and low diastolic blood pressure predict cardiovascular morbidity and mortality following discharge in acute decompensated heart failure patients.
|
Circ J
|
2012
|
1.40
|
|
16
|
Prognostic Impacts of Metabolic Syndrome in Patients With Chronic Heart Failure - A Multicenter Prospective Cohort Study.
|
Circ J
|
2016
|
1.39
|
|
17
|
Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities.
|
J Cell Biol
|
2003
|
1.36
|
|
18
|
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation.
|
Am J Physiol Heart Circ Physiol
|
2002
|
1.31
|
|
19
|
PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts.
|
J Mol Cell Cardiol
|
2008
|
1.20
|
|
20
|
Evaluation of intramitochondrial ATP levels identifies G0/G1 switch gene 2 as a positive regulator of oxidative phosphorylation.
|
Proc Natl Acad Sci U S A
|
2013
|
1.02
|
|
21
|
Identification of genes related to heart failure using global gene expression profiling of human failing myocardium.
|
Biochem Biophys Res Commun
|
2010
|
1.01
|
|
22
|
Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
|
Hypertens Res
|
2008
|
1.01
|
|
23
|
Pre- and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. -Single center's experience in japan-.
|
Circ J
|
2011
|
1.00
|
|
24
|
Ménage-à-trois 1 is critical for the transcriptional function of PPARgamma coactivator 1.
|
Cell Metab
|
2007
|
1.00
|
|
25
|
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
|
Circulation
|
2004
|
1.00
|
|
26
|
Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
|
Hypertension
|
2003
|
0.99
|
|
27
|
Improved long-term performance of pulsatile extracorporeal left ventricular assist device.
|
J Cardiol
|
2010
|
0.98
|
|
28
|
Lamr1 functional retroposon causes right ventricular dysplasia in mice.
|
Nat Genet
|
2004
|
0.95
|
|
29
|
Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
|
Eur J Heart Fail
|
2013
|
0.93
|
|
30
|
X-box binding protein 1 regulates brain natriuretic peptide through a novel AP1/CRE-like element in cardiomyocytes.
|
J Mol Cell Cardiol
|
2010
|
0.90
|
|
31
|
Usefulness of plasma brain natriuretic peptide concentration for predicting subsequent left ventricular remodeling after coronary angioplasty in patients with acute myocardial infarction.
|
Am J Cardiol
|
2006
|
0.87
|
|
32
|
Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
|
Hypertens Res
|
2008
|
0.87
|
|
33
|
S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts.
|
J Mol Cell Cardiol
|
2007
|
0.87
|
|
34
|
Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings.
|
Heart Vessels
|
2011
|
0.86
|
|
35
|
Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.86
|
|
36
|
A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.
|
Basic Res Cardiol
|
2010
|
0.86
|
|
37
|
Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects.
|
Hypertens Res
|
2008
|
0.86
|
|
38
|
Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
|
Cardiovasc Res
|
2005
|
0.85
|
|
39
|
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model.
|
Cardiovasc Drugs Ther
|
2013
|
0.84
|
|
40
|
Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation.
|
Biochem Biophys Res Commun
|
2005
|
0.84
|
|
41
|
Plasma adiponectin levels predict cardiovascular events in the observational Arita Cohort Study in Japan: the importance of the plasma adiponectin levels.
|
Hypertens Res
|
2012
|
0.83
|
|
42
|
Utility of left ventricular systolic torsion derived from 2-dimensional speckle-tracking echocardiography in monitoring acute cellular rejection in heart transplant recipients.
|
J Heart Lung Transplant
|
2010
|
0.83
|
|
43
|
H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs.
|
Cardiovasc Drugs Ther
|
2012
|
0.82
|
|
44
|
Antihypertrophic effects of adiponectin on cardiomyocytes are associated with the inhibition of heparin-binding epidermal growth factor signaling.
|
Biochem Biophys Res Commun
|
2010
|
0.82
|
|
45
|
Blockade of histamine H2 receptors protects the heart against ischemia and reperfusion injury in dogs.
|
J Mol Cell Cardiol
|
2006
|
0.82
|
|
46
|
Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart.
|
J Am Coll Cardiol
|
2002
|
0.82
|
|
47
|
Impact of physical activity on cardiovascular events in patients with chronic heart failure. A multicenter prospective cohort study.
|
Circ J
|
2013
|
0.81
|
|
48
|
Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase.
|
J Am Coll Cardiol
|
2002
|
0.81
|
|
49
|
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
|
Circulation
|
2004
|
0.81
|
|
50
|
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice.
|
Eur Heart J
|
2011
|
0.80
|
|
51
|
Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure.
|
J Cardiol
|
2011
|
0.80
|
|
52
|
Isoform-specific intermolecular disulfide bond formation of heterochromatin protein 1 (HP1).
|
J Biol Chem
|
2010
|
0.80
|
|
53
|
Utility of echocardiographic evaluation of donor hearts upon the organ procurement for heart transplantation.
|
J Cardiol
|
2011
|
0.80
|
|
54
|
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
|
J Cardiovasc Pharmacol
|
2004
|
0.79
|
|
55
|
Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure.
|
J Card Fail
|
2008
|
0.79
|
|
56
|
Comparison of time of reperfusion during anterior wall acute myocardial infarction to left ventricular volume one month and 20 months later.
|
Am J Cardiol
|
2002
|
0.78
|
|
57
|
Derivation of a mathematical expression for predicting the time to cardiac events in patients with heart failure: a retrospective clinical study.
|
Hypertens Res
|
2012
|
0.78
|
|
58
|
CB1 cannabinoid receptor deficiency promotes cardiac remodeling induced by pressure overload in mice.
|
Int J Cardiol
|
2012
|
0.77
|
|
59
|
Impact of Either GLP-1 Agonists or DPP-4 Inhibitors on Pathophysiology of Heart Failure.
|
Int Heart J
|
2015
|
0.77
|
|
60
|
Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release.
|
J Cardiovasc Pharmacol
|
2003
|
0.76
|
|
61
|
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
|
J Am Coll Cardiol
|
2002
|
0.76
|
|
62
|
Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
|
J Cardiol
|
2012
|
0.75
|
|
63
|
Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP).
|
Circ J
|
2004
|
0.75
|
|
64
|
Evaluation of volume depletion in patients with heart failure using intrathoracic impedance monitoring.
|
Circ J
|
2012
|
0.75
|
|
65
|
Noninvasive and quantitative live imaging reveals a potential stress-responsive enhancer in the failing heart.
|
FASEB J
|
2014
|
0.75
|
|
66
|
Do Japanese patients with myocardial infarction and left ventricular dysfunction require prophylactic implantable cardioverter-defibrillator implantation?
|
Circ J
|
2014
|
0.75
|
|
67
|
[Classification and feature of ischmic cardiomyopathy].
|
Nihon Rinsho
|
2011
|
0.75
|
|
68
|
Data Mining as a Powerful Tool for Creating Novel Drugs in Cardiovascular Medicine: The Importance of a "Back-and-Forth Loop" Between Clinical Data and Basic Research.
|
Cardiovasc Drugs Ther
|
2015
|
0.75
|
|
69
|
Comparative expression and tissue distribution analyses of astacin-like squid metalloprotease in squid and cuttlefish.
|
Zoolog Sci
|
2008
|
0.75
|
|
70
|
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
|
J Cardiol
|
2003
|
0.75
|
|
71
|
[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart].
|
J Cardiol
|
2002
|
0.75
|
|
72
|
Japan expects decrements in both the incidence and mortality of acute myocardial infarction in the modern era: likely or just a dream?
|
Circ J
|
2010
|
0.75
|
|
73
|
Clinical course and outcome of heart transplant recipients: single center experience at the National Cardiovascular Center in Japan.
|
Int Heart J
|
2010
|
0.75
|